The OBservations Podcast

We're taking a break from curbside consult material to bring you an update to a federal lawsuit that may have implications for your patients. In  the first of this two-part episode, attorney Erik Baptist, senior counsel for the Alliance Defending Freedom, and host Dr. Christina Francis offer an explanation of the federal lawsuit challenging the FDA's approval of the chemical abortion drugs mifepristone and misoprostol that's currently moving through the courts, The Alliance for Hippocratic Medicine v. FDA. Topics include what this lawsuit is about, a brief history of mifepristone in the United States, and a summary of the developments in this case.

Get updates on this case from the Alliance Defending Freedom:

• Twitter
• Instagram
• Facebook
• YouTube

Erik Baptist is the lead attorney representing the plaintiffs in AHM v FDA. He serves as senior counsel for the Alliance Defending Freedom, focusing on administrative litigation and regulatory advocacy. Before working at ADF, he was a partner at one of the largest law firms in Washington, DC, and a senior executive service political appointee at the US Environmental Protection Agency. Erik is admitted to practice before the US Supreme Court and several federal courts of appeal and so he definitely brings a great depth of experience and knowledge to this case.  

Learn more about us at www.aaplog.org

Become a member at www.aaplog.org/join

Join our mailing list here.

Click here to donate.

Follow us on:
Facebook
Twitter
Instagram

In this episode, Dr. Susan Bane and Kristen Eckenweiler, Medical Director and Patient Services Director at a pregnancy resource center in North Carolina, offer advice for medical professionals on how to navigate abortion decisions and more.

Dr. Susan Bane is a board-certified OB-GYN based in North Carolina. She serves as the Medical Director of Choices Women’s Center, and is an AAPLOG Board Member. She is also on faculty at Barton College. 

Kristen Eckenweiler, M.Ed. is the Client Services Director of this same clinic, where she oversees all client activities, as well as all resources, training and evaluation of all Client Advocates and Volunteers in the center. She also served as Vice Chair on the Board of Directors for Choices for 7 years. 

Learn more about us at www.aaplog.org

Become a member at www.aaplog.org/join

Join our mailing list here.

Click here to donate.

Follow us on:
Facebook
Twitter
Instagram

In the first of this two-part episode, Susan Bane, MD, PhD, and Kristen Eckenweiler, MEd speak to their experience caring for patients in a pregnancy resource center, including the services such organizations provide to women facing tough pregnancy decisions, and how physicians can speak to women considering abortion in their practice.

Dr. Susan Bane is a board-certified OB-GYN based in North Carolina. She serves as the Medical Director of Choices Women’s Center, and is an AAPLOG Board Member. She is also on faculty at Barton College. 

Kristen Eckenweiler, M.Ed. is the Client Services Director of this same clinic, where she oversees all client activities, as well as all resources, training and evaluation of all Client Advocates and Volunteers in the center. She also served as Vice Chair on the Board of Directors for Choices for 7 years. 

Learn more about us at www.aaplog.org

Become a member at www.aaplog.org/join

Join our mailing list here.

Click here to donate.

Follow us on:
Facebook
Twitter
Instagram

Dr. George Delgado, founder of the Abortion Pill Reversal program, discusses the theory, evidence, and critiques of abortion pill reversal, or the use of natural progesterone to reverse the effects of mifepristone. 

Dr. George Delgado is a board member at AAPLOG. He is also the president of Steno Institute and medical consultant to the Abortion Pill Rescue Network. He published two case studies in the peer-reviewed medical literature describing the reversal of mifepristone using progesterone. He also established Abortion Pill Reversal, a program that connects women who have changed their minds after taking mifepristone (RU 486) and want to reverse the effects of the abortion pill. APR also seeks to refine and improve the treatment protocols for reversing mifepristone. He is board certified in family medicine and in hospice and palliative medicine. 

Learn more about us at www.aaplog.org

Become a member at www.aaplog.org/join

Join our mailing list here.

Click here to donate.

Follow us on:
Facebook
Twitter
Instagram

In this introductory episode, we answer foundational questions about life-affirming medicine.

Our guest is Dr. Karysse Trandem, a board-certified OB-GYN, assistant professor of obstetrics and gynecology at the University of Central Florida College of Medicine, nonprofit CEO, and speaker who brings award-winning care to her patients internationally and global expertise to the government, hospital, business, and community audiences she teaches.

Learn more about us at www.aaplog.org

Become a member at www.aaplog.org/join

Join our mailing list here.

Click here to donate.

Follow us on:
Facebook
Twitter
Instagram